Literature DB >> 25135194

The use of research evidence on patient preferences in health care decision-making: issues, controversies and moving forward.

Carmen D Dirksen1.   

Abstract

Patient preferences are increasingly considered important in health care decision-making. The consideration of patient preferences is mostly put into practice by giving patients a seat at the decision-making table, instead of using research evidence on patient preferences. The consideration of research evidence on patient preferences is justified and relevant for several reasons. The current limited use of this type of evidence suggests, however, that barriers for its use exist. This paper provides an overview of the issues and controversies related to the use of research evidence on patient preferences. Furthermore, an agenda for research and practice is proposed. The paper focuses on two decision contexts, clinical practice guideline development and reimbursement decision-making.

Entities:  

Keywords:  clinical practice guideline; coverage; economic evaluation; evidence-based medicine; health technology assessment; patient preference; reimbursement

Mesh:

Year:  2014        PMID: 25135194     DOI: 10.1586/14737167.2014.948852

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  13 in total

1.  How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.

Authors:  Monique Wessels; Lian Hielkema; Trudy van der Weijden
Journal:  J Med Libr Assoc       Date:  2016-10

2.  Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.

Authors:  Mickaël Hiligsmann; Benedict G Dellaert; Carmen D Dirksen; Verity Watson; Sandrine Bours; Stefan Goemaere; Jean-Yves Reginster; Christian Roux; Bernie McGowan; Carmel Silke; Bryan Whelan; Adolfo Diez-Perez; Elisa Torres; Georgios Papadakis; Rene Rizzoli; Cyrus Cooper; Gill Pearson; Annelies Boonen
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

3.  Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.

Authors:  Jinsong Geng; Haini Bao; Zhe Feng; Jingyi Meng; Xiaolan Yu; Hao Yu
Journal:  BMC Public Health       Date:  2022-10-05       Impact factor: 4.135

4.  I. Indices of Pain Intensity Derived From Ecological Momentary Assessments: Rationale and Stakeholder Preferences.

Authors:  Arthur A Stone; Joan E Broderick; Roberta E Goldman; Doerte U Junghaenel; Alicia Bolton; Marcella May; Stefan Schneider
Journal:  J Pain       Date:  2020-09-15       Impact factor: 5.820

Review 5.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

6.  Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).

Authors:  Merel L Kimman; Adrienne H Rotteveel; Marlies Wijsenbeek; Rémy Mostard; Nelleke C Tak; Xana van Jaarsveld; Marjolein Storm; Kioa L Wijnsma; Marielle Gelens; Nicole C A J van de Kar; Jack Wetzels; Carmen D Dirksen
Journal:  Patient       Date:  2017-10       Impact factor: 3.883

7.  Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.

Authors:  Rosanne Janssens; Selena Russo; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Karin Schölin Bywall; Alina Comanescu; Axel Hueber; Matthias Englbrecht; Nikoletta Nikolenko; Gabriella Pravettoni; Steven Simoens; Hilde Stevens; Richard Hermann; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk; Isabelle Huys
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

8.  Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.

Authors:  Rosanne Janssens; Eline van Overbeeke; Lotte Verswijvel; Lissa Meeusen; Carolien Coenegrachts; Kim Pauwels; Marc Dooms; Hilde Stevens; Steven Simoens; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2018-10-11

9.  Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire.

Authors:  Merel L Kimman; Marlies S Wijsenbeek; Sander M J van Kuijk; Kioa L Wijnsma; Nicole C A J van de Kar; Marjolein Storm; Xana van Jaarsveld; Carmen D Dirksen
Journal:  Patient       Date:  2019-02       Impact factor: 3.883

10.  Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

Authors:  Rosanne Janssens; Isabelle Huys; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Antonio Ciaglia; Steven Simoens; Hilde Stevens; Meredith Smith; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-04       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.